Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 285
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First Look at Gilgamesh’s Phase 2a Data; ASCP 2025 Preview; VA Sec. Pressed on...
EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans
Ibogaine – The Promise, the Protocol, and Protecting the Sacred
Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business...
“Neuropharmacology: Psychedelics on the Brain” – Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
Insight into Ayahuasca’s Antidepressant Effects
New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research
The Role of Oxytocin in MDMA’s Prosocial Effects
The Ancestral Healing Power of Ayahuasca
Pharmacological Testing in Psychedelic Research
Catching Up with the Psychedelic Entourage Effect: Part 4 – CaaMTech
Ayahuasca’s Role in the Entourage Effect and Depression
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet...
MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing
1
...
284
285
286
Page 285 of 286
